What Does FDA’s Reorganization Mean for the Dietary Supplement Industry?

Mapping The Nutraceuticals World

Loren Israelsen from the United Natural Products Alliance shares insight on how agency priorities might change and how businesses can prepare.
The U.S. Food and Drug Administration is in process of a massive reorganization designed to streamline operations within a unified Human Foods Program (HFP) to largely replace the Center for Food Safety and Applied Nutrition (CFSAN).
What does this mean for the dietary supplement industry?
In the proposal, now under review at Health and Human Services (HHS), the Office of Dietary Supplement Programs (ODSP) will report to a newly created “Office of Food Chemical Safety, Dietary Supplements, and Innovation,” (OFCSDSI), which FDA said “will work to modernize and strengthen oversight of food chemical safety, advance dietary supplement safety, and enable the Human Foods Program to support and effectively regulate food ingredient innovation.”
As the agency’s first Deputy Commissioner of Human Foods, Jim Jones is a 30-year veteran of the Environmental Protection Agency (EPA) with a deep background in chemical safety. Jones and his staff met last December with several major trade associations representing the supplements industry, including Loren Israelsen, founder and president of the United Natural Products Alliance.
I talked with Loren recently about FDA’s restructuring and how priorities might change under an overhauled Human Foods Program with new leadership.
— Sean Moloughney, Editor, Nutraceuticals World, [e-mail]